Protara Therapeutics, Inc. - TARA
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 02, 2026 | SCHEDULE 13G | Millennium Management LLC | 5.1% | 2,759,231 | View |
| Mar 02, 2026 | SCHEDULE 13G | Millennium Group Management LLC | 5.1% | 2,759,231 | View |
| Mar 02, 2026 | SCHEDULE 13G | Israel A. Englander | 5.1% | 2,759,231 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | JANUS HENDERSON GROUP PLC | 10.0% | 5,141,616 | View |
| Jan 21, 2026 | SCHEDULE 13G/A | BlackRock, Inc. | 4.7% | 2,408,868 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | JANUS HENDERSON GROUP PLC | 11.0% | 4,231,331 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Janus Henderson Biotech Innovation Master Fund Ltd | 9.3% | 3,579,068 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.